Speakers Speeches

Back

SAN LORENZO
December, 06th | 09:03 - 09:06
Phase 2a/proof of concept study with anxv ( recombinant human annexin a5) in patients with retinal vein occlusion
FROSTEGÅRD ANNA
Full program Add to calendar